These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15611842)

  • 1. Placebo-controlled trials in major depression are necessary and ethically justifiable: how to improve the communication between researchers and ethical committees.
    Adam D; Kasper S; Möller HJ; Singer EA;
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):258-60. PubMed ID: 15611842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ethical implications of placebo-controlled clinical trials for psychotropic drugs].
    Helmchen H
    Nervenarzt; 2005 Nov; 76(11):1319-29. PubMed ID: 15812676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled studies in depression: necessary, ethical and feasible.
    Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia.
    Carpenter WT; Appelbaum PS; Levine RJ
    Am J Psychiatry; 2003 Feb; 160(2):356-62. PubMed ID: 12562584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders.
    Dunlop BW; Banja J
    J Med Ethics; 2009 Jun; 35(6):384-9. PubMed ID: 19482985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is it ethical conducting placebo-controlled clinical trials as part of the development of new drugs for the treatment of major depressive disorder? (I). Considerations on the value and scientific validity of the study].
    Gracia D; Lahuerta J; Carné X; Dal-Ré R
    Med Clin (Barc); 2004 Oct; 123(14):546-50. PubMed ID: 15535930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is the placebo still ethically acceptable and scientifically useful in clinical drug experimentation?].
    Mariani L; Ventresca GP
    Clin Ter; 1996 Nov; 147(11):595-8. PubMed ID: 9264914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control].
    Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):541-7. PubMed ID: 15887064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compare new therapies with old, not with a placebo: a plea for revision of the Declaration of Helsinki].
    Willems DL; Ploem MC; Vermeulen MR
    Ned Tijdschr Geneeskd; 2013; 157(45):A6542. PubMed ID: 24191926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk, Helsinki 2000 and the use of placebo in medical research.
    Saunders J; Wainwright P
    Clin Med (Lond); 2003; 3(5):435-9. PubMed ID: 14601942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is it still ethical to conduct clinical trials against a placebo? A review of the ethical and methodological controversy].
    Bouvenot G
    Presse Med; 2003 Jun; 32(21):966-71. PubMed ID: 12876524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trials and the Declaration of Helsinki.
    Lewis JA; Jonsson B; Kreutz G; Sampaio C; van Zwieten-Boot B
    Lancet; 2002 Apr; 359(9314):1337-40. PubMed ID: 11965296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues related to the use of placebo in clinical trials.
    Lau JT; Mao J; Woo J
    Hong Kong Med J; 2003 Jun; 9(3):192-8. PubMed ID: 12777655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The necessity and the value of placebo.
    Singer EA
    Sci Eng Ethics; 2004 Jan; 10(1):51-6. PubMed ID: 14986771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International collaborative trials, placebo controls and The Declaration of Helsinki: need for clarification in paragraph 32.
    Malik AY; Ghafoor F
    Indian J Med Ethics; 2012; 9(1):13-8. PubMed ID: 22319846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo: its action and place in health research today.
    Smoak R
    Sci Eng Ethics; 2004 Jan; 10(1):9-13. PubMed ID: 14986765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.